Tandem Diabetes Care Inc header image

Tandem Diabetes Care Inc

TNDM

Equity

ISIN null / Valor 38586336

NASDAQ (2026-03-10)
USD 21.88+4.79%

Tandem Diabetes Care Inc
UMushroom community rating:

star star star star star
4.40 5 votes No rating yet
NegativeNeutralPositive

About company

Tandem Diabetes Care, Inc. is a medical device company that designs, manufactures and sells insulin delivery systems and associated software for people who require insulin therapy, primarily addressing insulin-dependent diabetes. Its product line centers on the t:slim family of insulin pumps, including the t:slim X2 device that supports software features such as the Control‑IQ hybrid closed‑loop algorithm and interoperability with continuous glucose monitors (notably Dexcom systems), and the company also supplies infusion sets, cartridges and data‑management services through its t:connect platform. Headquartered in San Diego and publicly traded, Tandem generates revenue from hardware sales, consumable supplies and related software/services while investing in regulatory approvals, clinical development and product upgrades to expand its installed base in the U.S. and selected international markets.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

20.5%1Y
-41.9%3Y
-75.0%5Y

Performance

78.8%1Y
69.8%3Y
64.9%5Y

Volatility

Market cap

1495 M

Market cap (USD)

Daily traded volume (Shares)

1,533,314

Daily traded volume (Shares)

1 day high/low

37.01 / 35.66

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.40

5 votes
Performance:
starstarstarstarstar
4.00
Innovation:
starstarstarstarstar
4.25
Society:
starstarstarstarstar
4.25
Nature:
starstarstarstarstar
3.75
Vladimir Jovicic
Switzerland, 01 Mar 2023
star star star star star
Tonia Zimmermann
Switzerland, 01 Mar 2023
star star star star star
Promising upside potential
Igor Jovicic
Switzerland, 01 Mar 2023
star star star star star
Diabetes is a serious topic these days... But do you know why can’t diabetics have vengeance? --- Because vengeance is sweet.

EQUITIES OF THE SAME SECTOR

Worldline SA
Worldline SA Worldline SA Valor: 24715654
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.32%EUR 1.39
Nexans
Nexans Nexans Valor: 1242479
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.32%EUR 119.50
Atos SE
Atos SE Atos SE Valor: 167932
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-6.40%EUR 36.88
Neurones
Neurones Neurones Valor: 837153
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.43%EUR 35.15
Tietoevry Oyj
Tietoevry Oyj Tietoevry Oyj Valor: 472478
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.47%EUR 18.87
Revenio Group Oyj
Revenio Group Oyj Revenio Group Oyj Valor: 1304192
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.65%EUR 17.92
SAP SE
SAP SE SAP SE Valor: 345952
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.45%EUR 165.44
Rational AG
Rational AG Rational AG Valor: 635626
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.38%EUR 678.00
SMA Solar Technology AG
SMA Solar Technology AG SMA Solar Technology AG Valor: 4337414
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
6.35%EUR 33.48
Siltronic AG
Siltronic AG Siltronic AG Valor: 28423342
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.96%EUR 52.00